Efficacy of the BELA weight management programme to prevent increase of weight in schizophrenic patients treated with olanzapin (BELA = movement - nutrition - learning - accepting)
Completed
- Conditions
- SchizophreniaMental and Behavioural Disorders
- Registration Number
- ISRCTN23263429
- Lead Sponsor
- Heinrich-Heine University (Germany)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 180
Inclusion Criteria
1. Both males and females
2. Age 18 - 65 years
3. Criteria of the Diagnostic and Statistical Manual of Mental Disorders - Fourth Edition (DSM IV) for schizophrenia or schizoaffective psychosis
4. Written informed consent
5. Capability of signing informed consent
6. Olanzapin medication
Exclusion Criteria
1. Serious somatic diseases
2. Changes in weight due to somatic diseases
3. Pregnancy or lactation
4. Increase of weight of more than 3 kg over the last 3 months before start of treatment with olanzapin
5. Co-medication with a weight-reducing potential
6. Participation in another interventional trial which could interfere with this trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method